{
    "code": "02020323",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020323",
    "time": "2024-03-14 23:22:26",
    "許可證字號": "衛署藥輸字第020323號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/02\/16",
    "發證\/登錄日期": "107\/10\/23",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202032303",
    "中文品名": "安保胃膜衣錠１５０公絲",
    "英文品名": "APO-RANITIDINE 150MG F.C. TABLETS",
    "適應症": "十二指腸潰瘍、良性胃潰瘍，回流性食炎，邊緣性之消化性潰瘍高濃度胃酸分泌症侯群。",
    "劑型": "116膜衣錠",
    "包裝": "銀色鋁箔盒裝 4-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "RANITIDINE HCL",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "鴻汶醫藥實業有限公司",
    "申請商地址": "台中市西屯區文心路三段236號3樓、238號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "APOTEX INC.",
            "製造廠廠址": "150 SIGNET DRIVE,TORONTO,ONTARIO,CANADA M9L 1T9",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640001210",
            "成分名稱": "RANITIDINE HCL",
            "含量描述": "",
            "含量": "167.9000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓凸形",
        "標記一": "APO150",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Apo-Ranitidine 150mg 裸-105-05-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020323&Seq=425&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "v APO-RANITIDINE 150mg_20151206核定-105-06-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020323&Seq=003&Type=9"
        },
        {
            "title": "Apo-Ranitidine Tablets 150 mg_鋁箔-108-09-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020323&Seq=012&Type=8"
        },
        {
            "title": "Apo-Ranitidine Tablets 150 mg_外盒-108-09-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020323&Seq=011&Type=8"
        },
        {
            "title": "Apo-Ranitidine 150mg BLS 正反面.JPG-105-05-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020323&Seq=010&Type=8"
        },
        {
            "title": "Apo-Ranitidine 150mg 外盒正反面-105-05-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020323&Seq=009&Type=8"
        }
    ]
}